European PharmaNovo Nordisk's 24.9% Rally Backs AI Partnership Model Over In-House BiologySalvado•May 31, 2026
European PharmaNovo Nordisk Licenses Parkinson's Cell Therapy to AI Partner, Closes Internal UnitSalvado•May 16, 2026